Abstract
Previous studies indicate that the repeated administration of d-methylamphetamine (MA) produces a long-lasting depletion of dopamine (DA), norepinephrine (NE) and serotonin (5-hydroxytryptamine, 5-HT) in various brain regions of a number of species. The objectives of the present study were: (1) to establish a short, subcutaneous injection regimen which would reliably produce the neuronal alterations; (2) to evaluate MA-induced NE depletions produced by this new regimen; and (3) to determine whether central MA-induced neuronal changes are reflected in changes in cerebrospinal fluid monoamine metabolite concentrations. It was observed that high doses of MA administered (s.c) over a 2-week period to rhesus monkeys decreases in DA and 5-HT, but not NE levels, in various brain regions. The decrease in caudate DA levels was accompanied by a decrease in the number of DA uptake sites, a decrease in the level of homovanillic acid (HVA) and an increase in DA turnover. This decrease in brain DA was accompanied by a decrease in the cerebrospinal fluid concentration of HVA.
Original language | English (US) |
---|---|
Pages (from-to) | 243-248 |
Number of pages | 6 |
Journal | Brain research |
Volume | 338 |
Issue number | 2 |
DOIs | |
State | Published - Jul 15 1985 |
Keywords
- cerebrospinal fluid
- dopamine
- methylamphetamine
- rhesus monkeys
- serotonin
- toxicity
ASJC Scopus subject areas
- Neuroscience(all)
- Molecular Biology
- Clinical Neurology
- Developmental Biology